
Mohit Bansal
Stock Analyst at Wells Fargo
(4.76)
# 642
Out of 5,134 analysts
850
Total ratings
59%
Success rate
10.7%
Average return
Main Sectors:
Stocks Rated by Mohit Bansal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIST Milestone Pharmaceuticals | Maintained: Buy | $7 → $4 | $0.52 | +669.23% | 6 | Nov 16, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Buy | $30 | $14.15 | +112.01% | 15 | Nov 11, 2026 | |
| AMGN Amgen | Reiterated: Hold | $460 | $465.67 | -1.22% | 57 | Nov 8, 2026 | |
| HALO Halozyme Therapeutics | Rated: Hold | $95 → $110 | $100.27 | +9.70% | 28 | Nov 6, 2026 | |
| MLYS Mineralys Therapeutics | Reiterated: Buy | $55 | $15.33 | +258.77% | 17 | Nov 5, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $140 → $125 | $85.60 | +46.03% | 15 | Nov 4, 2026 | |
| PFE Pfizer | Rated: Hold | $28 | $28.89 | -3.08% | 56 | Nov 4, 2026 | |
| BMRN BioMarin Pharmaceutical | Rated: Buy | $80 | $57.23 | +39.79% | 30 | Nov 3, 2026 | |
| JAZZ Jazz Pharmaceuticals | Rated: Buy | $300 | $241.55 | +24.20% | 21 | Nov 3, 2026 | |
| NBIX Neurocrine Biosciences | Rated: Buy | $200 | $167.40 | +19.47% | 35 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 | $50.65 | +57.95% | 25 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $550 → $650 | $538.60 | +20.68% | 54 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 → $340 | $295.03 | +15.24% | 45 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 | $63.43 | -5.41% | 47 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $165 → $190 | $168.08 | +13.04% | 66 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $750 → $925 | $955.47 | -3.19% | 70 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $310 | $253.40 | +22.34% | 58 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,330 → $1,500 | $1,443.50 | +3.91% | 71 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $165 | $147.76 | +11.67% | 58 | Oct 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $28.10 | +149.11% | 13 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $37.09 | -19.12% | 1 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $4.83 | +3.52% | 16 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $3.13 | +315.34% | 1 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $40.48 | n/a | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $47.78 | n/a | 1 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $14 | $10.03 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.0001 | n/a | 1 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $0.697 | n/a | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $33 | $31.83 | n/a | 2 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $27 | $0.5255 | n/a | 6 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $75 | $4.65 | n/a | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $5 | $0.0003 | n/a | 5 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $65 | $31.59 | n/a | 5 | Dec 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $8.5 | $2.04 | n/a | 4 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $0.03 | n/a | 2 | Apr 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $15.54 | n/a | 1 | Jun 11, 2019 |
Milestone Pharmaceuticals
Nov 16, 2026
Maintained: Buy
Price Target: $7 → $4
Current: $0.52
Upside: +669.23%
Summit Therapeutics
Nov 11, 2026
Reiterated: Buy
Price Target: $30
Current: $14.15
Upside: +112.01%
Amgen
Nov 8, 2026
Reiterated: Hold
Price Target: $460
Current: $465.67
Upside: -1.22%
Halozyme Therapeutics
Nov 6, 2026
Rated: Hold
Price Target: $95 → $110
Current: $100.27
Upside: +9.70%
Mineralys Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $55
Current: $15.33
Upside: +258.77%
BioNTech SE
Nov 4, 2026
Reiterated: Buy
Price Target: $140 → $125
Current: $85.60
Upside: +46.03%
Pfizer
Nov 4, 2026
Rated: Hold
Price Target: $28
Current: $28.89
Upside: -3.08%
BioMarin Pharmaceutical
Nov 3, 2026
Rated: Buy
Price Target: $80
Current: $57.23
Upside: +39.79%
Jazz Pharmaceuticals
Nov 3, 2026
Rated: Buy
Price Target: $300
Current: $241.55
Upside: +24.20%
Neurocrine Biosciences
Nov 3, 2026
Rated: Buy
Price Target: $200
Current: $167.40
Upside: +19.47%
Nov 3, 2026
Rated: Buy
Price Target: $80
Current: $50.65
Upside: +57.95%
Nov 2, 2026
Reiterated: Buy
Price Target: $550 → $650
Current: $538.60
Upside: +20.68%
Oct 30, 2026
Reiterated: Buy
Price Target: $300 → $340
Current: $295.03
Upside: +15.24%
Oct 30, 2026
Reiterated: Hold
Price Target: $60
Current: $63.43
Upside: -5.41%
Oct 30, 2026
Rated: Buy
Price Target: $165 → $190
Current: $168.08
Upside: +13.04%
Oct 30, 2026
Reiterated: Hold
Price Target: $750 → $925
Current: $955.47
Upside: -3.19%
Oct 29, 2026
Reiterated: Buy
Price Target: $310
Current: $253.40
Upside: +22.34%
Oct 29, 2026
Reiterated: Buy
Price Target: $1,330 → $1,500
Current: $1,443.50
Upside: +3.91%
Oct 26, 2026
Reiterated: Buy
Price Target: $165
Current: $147.76
Upside: +11.67%
Oct 15, 2026
Reiterated: Buy
Price Target: $70
Current: $28.10
Upside: +149.11%
Oct 15, 2026
Reiterated: Buy
Price Target: $30
Current: $37.09
Upside: -19.12%
May 5, 2026
Reiterated: Hold
Price Target: $5
Current: $4.83
Upside: +3.52%
Apr 1, 2026
Reiterated: Buy
Price Target: $13
Current: $3.13
Upside: +315.34%
Aug 12, 2025
Reiterated: Buy
Price Target: $47
Current: $40.48
Upside: n/a
Jul 2, 2021
Reiterated: Buy
Price Target: $95
Current: $47.78
Upside: n/a
Jun 29, 2021
Reiterated: Buy
Price Target: $30 → $14
Current: $10.03
Upside: n/a
Jun 4, 2021
Initiated Coverage: Buy
Price Target: $3
Current: $0.0001
Upside: n/a
Apr 5, 2021
Initiated Coverage: Buy
Price Target: $52
Current: $0.697
Upside: n/a
Mar 24, 2021
Reiterated: Buy
Price Target: $20 → $33
Current: $31.83
Upside: n/a
Feb 25, 2021
Reiterated: Buy
Price Target: $25 → $27
Current: $0.5255
Upside: n/a
Jan 20, 2021
Reiterated: Buy
Price Target: $36 → $75
Current: $4.65
Upside: n/a
Jan 5, 2021
Reiterated: Buy
Price Target: $10 → $5
Current: $0.0003
Upside: n/a
Dec 23, 2020
Reiterated: Buy
Price Target: $75 → $65
Current: $31.59
Upside: n/a
Sep 15, 2020
Reiterated: Hold
Price Target: $11 → $8.5
Current: $2.04
Upside: n/a
Apr 27, 2020
Reiterated: Buy
Price Target: $8 → $5
Current: $0.03
Upside: n/a
Jun 11, 2019
Initiated Coverage: Buy
Price Target: $21
Current: $15.54
Upside: n/a